Last reviewed · How we verify
HA administration
At a glance
| Generic name | HA administration |
|---|---|
| Also known as | Standard treatment (control) |
| Sponsor | Jagiellonian University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Administration site pain
- Headache
- Fatigue
- Myalgia
- Arthralgia
- Upper respiratory tract infection
- Injection site pain (PAIN AT THE INJECTION SITE)
- Fatigue (FATIGUE)
- Headache (HEADACHE)
- Myalgia (NEW OR WORSENED MUSCLE PAIN)
- Injection site erythema
- Administration site erythema
Key clinical trials
- Hyaluronic Acid and Albumin-PRF in Non-Surgical Periodontal Therapy (NA)
- Early vs Delayed Intravesical Blad-Care During BCG Therapy (NA)
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors (PHASE3)
- The Efficacy and Safety of a Single-Dose Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis
- Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases (PHASE3)
- "Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy" (NA)
- Use of Airpod Pros as Assistive Technology (NA)
- Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Municipalities (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HA administration CI brief — competitive landscape report
- HA administration updates RSS · CI watch RSS
- Jagiellonian University portfolio CI